WBIO — WPD Pharmaceuticals Balance Sheet
0.000.00%
- CA$0.32m
- CA$0.71m
Annual balance sheet for WPD Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.801 | 1.24 | 0.301 | 0.024 | 0.086 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.074 | 0.04 | 0.034 | 0.052 | 0.033 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.93 | 1.94 | 1.8 | 0.076 | 0.122 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 0.087 | 0.065 | 0 | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 3.93 | 2.68 | 1.86 | 0.076 | 0.346 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.96 | 1.58 | 5.92 | 0.555 | 0.598 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.96 | 1.58 | 5.92 | 0.555 | 0.902 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.974 | 1.11 | -4.06 | -0.479 | -0.556 |
Total Liabilities & Shareholders' Equity | 3.93 | 2.68 | 1.86 | 0.076 | 0.346 |
Total Common Shares Outstanding |